This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Glaxo Group Limited. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Adriaan Allart Stoop: Innovator in Therapeutic Antibodies
Introduction
Adriaan Allart Stoop is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of therapeutic antibodies, holding a total of 2 patents. His work focuses on innovative solutions for treating diseases associated with TGF-beta signaling and inflammatory conditions.
Latest Patents
Stoop's latest patents include "Ligands that bind TGF-β receptor RII," which provides an anti-TGFbetaRII immunoglobulin single variable domain. This invention also encompasses a polypeptide, ligand, or pharmaceutical composition aimed at treating diseases such as tissue fibrosis, rheumatoid arthritis, ocular disorders, and various kidney conditions. Another notable patent is for "Stable anti-TNFR1 polypeptides, antibody variable domains and antagonists." This invention relates to storage-stable anti-TNFR1 antibody single variable domains, antagonists, and multispecific ligands, which are useful for treating inflammatory diseases like arthritis and COPD.
Career Highlights
Adriaan Stoop is currently associated with Glaxo Group Limited, where he continues to advance his research and development efforts in the field of therapeutic antibodies. His innovative work has the potential to significantly impact the treatment of various chronic diseases.
Collaborations
Stoop has collaborated with notable colleagues, including Caroline Dimech and Rudolf Maria De Wildt, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Adriaan Allart Stoop is a key figure in the development of therapeutic antibodies, with a focus on addressing critical health challenges. His patents reflect a commitment to advancing medical science and improving patient outcomes.